OncoSwab

Management Team

Andrea Stephany, MSc
Co-founder and CEO
San Francisco, USA

Andrea holds a Master’s in Molecular Biotechnology and is recognized as one of Europe's top 100 young scientists. A seasoned science communicator and co-inventor of OncoSwab's cutting-edge technology, she has also contributed her insights as a panelist at the European Commission in Brussels, advancing the conversation on entrepreneurship globally.

Pablo Lara, PhD
Co-founder and CSO
Basel, Switzerland

Dr. Pablo Lara holds a Ph.D. in Pharmacology and boasts over a decade of combined experience in academia and industry. His research has significantly contributed to the development and commercialization of marketable products like Nanofix® and Machetune, leading to multiple patents and licensing deals. An accomplished scientist, Dr. Lara has authored numerous peer-reviewed publications, reflecting his deep commitment to advancing medical science.

Javier Zulueta, MD
Clinician co-founder
New York, USA

Dr. Javier Zulueta, Chief of Pulmonary Medicine at Mount Sinai Morningside, is a globally recognized leader in pulmonology and a pioneer in lung cancer screening. He established Europe’s first and longest-running lung cancer screening program, significantly advancing early detection methodologies. Dr. Zulueta's expertise extends to designing clinical trials and overseeing quality assurance and regulatory affairs, ensuring rigorous standards in research and patient care.

Roberta Gatta, PhD
Clinical operations specialist
Naples, Italy

Roberta Gatta, PhD in Biotechnology and clinical operations specialist at OncoSwab, orchestrates the company's multi-centric clinical trials. Selected as a Women2Invest figure by the European Institute of Innovation and Technology, Roberta combines her profound scientific expertise with strategic investment insights, honed through her experience in healthcare venture capital at EureKARE.

Nadja Wipp-Fürle
Regulatory Affairs and Policy Fellow
San Francisco, USA

With an MSc in Human Rights from the London School of Economics, Nadja's background in regulatory affairs and international law uniquely positions her to navigate complex regulatory challenges and drive impactful policy integration.

Redefining Lung Cancer Detection!

Our team is committed to saving lives through simpler and accessible detection.

Our Advisors

Scott Jacobson

VP of US Strategy at Cigna Healthcare

Mike Doherty

Former Head of Regulatory Affairs at Roche, former Head of Product at Foundation Medicine

David Esposito

Former CEO fo Armune Biosciences (Acq: Exact Sciences), former US President of Fadia (Acq: Thermo Fisher Scientific)

Steve Bell

Former Chief Commercialization Officer CMR Surgical (biggest unicorn in Europe)

Julie Ballard

CLIA-lab and LDT development expert

Our Medical Team

Dr. Javier Zulueta
New York, USA

Chief of Pulmonary, Critical Care and Sleep Medicine, Mount Sinai Morningside.

Dr. Yaron Gesthalter
San Francisco, USA

Interventional pulmonologist, UCSF

Dr. Konstantinos Giustos
Bern, Switzerland

Thoracic surgeon, Inselspital Bern.

Dr. Miguel Ariza Prota
Asturias, Spain

Interventional bronchoscopist, Hospital Universitario Central de Asturias.

Onco
Swab